---
$id: https://graph.org.ai/products/commodity/51111763
$type: Product
source: UNSPSC
code: "51111763"
title: "Soblidotin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Soblidotin

**UNSPSC Code**: 51111763
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca-site binding agent and dolastatin compound with the molecular formula C39H67N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQC51A0WQH, chemically known as n(2)-(n,n-dimethyl-valyl)-n-(2-methoxy-4-(2-(1-methoxy-2-methyl-3-oxo-3-((2-phenylethyl)amino)propyl)-1-pyrrolidinyl)-1-(1-methylpropyl)-4-oxobutyl)-n-methyl-valinamide but generally known as soblidotin, which bears US NIH Compound Identifier 124092. The term SOBLIDOTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). Most nations schedule soblidotin under HS 29339990 and SITC 51577. As of Q4 2014, SOBLIDOTIN remains the US FDA Preferred Term for this commodity. Soblidotin bears US NLM identifiers UMLS ID C1328702 and NCI Concept Code C26672. SMILES: CCC(C)C(C(CC(=O)N1CCC(C1)C(C(C)C(=O)NCCC2=CC=CC=C2)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C.

